In the last decades, the role of the microenvironment in tumor progression and therapeutic outcome has gained increasing attention. Cancer-associated fibroblasts (CAFs) have emerged as key players among stromal cells, owing to their abundance in most solid tumors and their diverse tumor-restraining/promoting roles. The interplay between tumor cells and neighboring CAFs takes place by both paracrine signals (cytokines, exosomes and metabolites) or by the multifaceted functions of the surrounding extracellular matrix. Here, we dissect the most recent identified mechanisms underlying CAF-mediated control of tumor progression and therapy resistance, which include induction of the epithelial-to-mesenchymal transition (EMT), activation of survival pathways or stemness-related programs and metabolic reprogramming in tumor cells. Importantly, the recently unveiled heterogeneity in CAFs claims tailored therapeutic efforts aimed at eradicating the specific subset facilitating tumor progression, therapy resistance and relapse. However, despite the large amount of pre-clinical data, much effort is still needed to translate CAF-directed anti-cancer strategies from the bench to the clinic.

Fiori, M. E., Di Franco, S., Villanova, L., Bianca, P., Stassi, G., De Maria, R., Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance, <<MOLECULAR CANCER>>, 2019; 18 (1): 70-N/A. [doi:10.1186/s12943-019-0994-2] [http://hdl.handle.net/10807/133832]

Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance

Fiori, Micol Eleonora;Villanova, Lidia;De Maria, Ruggero
Ultimo
2019

Abstract

In the last decades, the role of the microenvironment in tumor progression and therapeutic outcome has gained increasing attention. Cancer-associated fibroblasts (CAFs) have emerged as key players among stromal cells, owing to their abundance in most solid tumors and their diverse tumor-restraining/promoting roles. The interplay between tumor cells and neighboring CAFs takes place by both paracrine signals (cytokines, exosomes and metabolites) or by the multifaceted functions of the surrounding extracellular matrix. Here, we dissect the most recent identified mechanisms underlying CAF-mediated control of tumor progression and therapy resistance, which include induction of the epithelial-to-mesenchymal transition (EMT), activation of survival pathways or stemness-related programs and metabolic reprogramming in tumor cells. Importantly, the recently unveiled heterogeneity in CAFs claims tailored therapeutic efforts aimed at eradicating the specific subset facilitating tumor progression, therapy resistance and relapse. However, despite the large amount of pre-clinical data, much effort is still needed to translate CAF-directed anti-cancer strategies from the bench to the clinic.
Inglese
Fiori, M. E., Di Franco, S., Villanova, L., Bianca, P., Stassi, G., De Maria, R., Cancer-associated fibroblasts as abettors of tumor progression at the crossroads of EMT and therapy resistance, <<MOLECULAR CANCER>>, 2019; 18 (1): 70-N/A. [doi:10.1186/s12943-019-0994-2] [http://hdl.handle.net/10807/133832]
File in questo prodotto:
File Dimensione Formato  
Cancer-associated fibroblasts as abettors of.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.55 MB
Formato Adobe PDF
1.55 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/133832
Citazioni
  • ???jsp.display-item.citation.pmc??? 153
  • Scopus 236
  • ???jsp.display-item.citation.isi??? 237
social impact